Robert Lyndsay Sutherland
#115,440
Most Influential Person Now
Robert Lyndsay Sutherland's AcademicInfluence.com Rankings
Robert Lyndsay Sutherlandphilosophy Degrees
Philosophy
#4998
World Rank
#7695
Historical Rank
Logic
#2349
World Rank
#3325
Historical Rank
Robert Lyndsay Sutherlandbiology Degrees
Biology
#6650
World Rank
#9413
Historical Rank
Genetics
#625
World Rank
#708
Historical Rank
Download Badge
Philosophy Biology
Robert Lyndsay Sutherland's Degrees
- PhD Genetics Stanford University
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Robert Lyndsay Sutherland Influential?
(Suggest an Edit or Addition)Robert Lyndsay Sutherland's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genomic analyses identify molecular subtypes of pancreatic cancer (2016) (2343)
- International network of cancer genome projects (2010) (1839)
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes (2012) (1752)
- Biological determinants of endocrine resistance in breast cancer (2009) (1199)
- Cyclin D as a therapeutic target in cancer (2011) (1187)
- Expression and amplification of cyclin genes in human breast cancer. (1993) (730)
- Progestin regulation of cellular proliferation. (1990) (668)
- Estrogen-induced Activation of Cdk4 and Cdk2 during G1-S Phase Progression Is Accompanied by Increased Cyclin D1 Expression and Decreased Cyclin-dependent Kinase Inhibitor Association with Cyclin E-Cdk2* (1997) (453)
- Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum (2003) (428)
- Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. (1994) (395)
- A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. (2003) (393)
- Prolactin controls mammary gland development via direct and indirect mechanisms. (1999) (360)
- High-affinity anti-oestrogen binding site distinct from the oestrogen receptor (1980) (360)
- Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. (2009) (341)
- Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. (2003) (327)
- Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. (1993) (324)
- Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. (1983) (315)
- Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. (2009) (312)
- PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortality (2010) (285)
- Cyclin D1, EMS1 and 11q13 Amplification in Breast Cancer (2003) (275)
- Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers (2010) (274)
- Frequent Loss of Estrogen Receptor-β Expression in Prostate Cancer (2001) (269)
- c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry (1998) (259)
- Cyclins and Breast Cancer (1996) (256)
- Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes (1991) (254)
- Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E. (2005) (241)
- Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. (1999) (241)
- Margin clearance and outcome in resected pancreatic cancer. (2009) (238)
- Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. (2003) (234)
- The prognostic and predictive value of serum CA19.9 in pancreatic cancer (2012) (229)
- Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle. (1983) (228)
- Common Activation of Canonical Wnt Signaling in Pancreatic Adenocarcinoma (2007) (223)
- Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. (1994) (220)
- Overexpression of the Cell Adhesion Molecules DDR1, Claudin 3, and Ep-CAM in Metaplastic Ovarian Epithelium and Ovarian Cancer (2004) (219)
- Cell cycle control in breast cancer cells (2006) (217)
- Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer. (1999) (214)
- An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. (2005) (213)
- Molecular markers of prostate cancer outcome. (2005) (211)
- International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. (2002) (205)
- Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer. (2001) (199)
- Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. (1995) (197)
- Regional activation of the cancer genome by long-range epigenetic remodeling. (2013) (185)
- The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy (2009) (182)
- Aberrant p16INK4A and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma (2002) (180)
- Tamoxifen is a potent ‘pure’ anti-oestrogen in chick oviduct (1977) (179)
- Frequent loss of estrogen receptor-beta expression in prostate cancer. (2001) (176)
- Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells. (2010) (172)
- Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. (1998) (169)
- Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. (1985) (167)
- Estrogen regulation of cell cycle progression in breast cancer cells 1 1 Proceedings of the 13th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology “Recent Advances in Steroid Biochemistry & Molecular Biology” Monaco 25–28 May 1997. (1998) (165)
- DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma. (2002) (165)
- Cyclin D1, p53, and p21Waf1/Cip1 Expression Is Predictive of Poor Clinical Outcome in Serous Epithelial Ovarian Cancer (2004) (162)
- Expression of HOXB2, a Retinoic Acid Signaling Target in Pancreatic Cancer and Pancreatic Intraepithelial Neoplasia (2005) (161)
- Expression and regulation of retinoic acid receptors in human breast cancer cells. (1992) (158)
- Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. (1988) (158)
- Spheroids in Cancer Research (1984) (158)
- Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. (2001) (154)
- Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer. (2011) (151)
- A Pure Estrogen Antagonist Inhibits Cyclin E-Cdk2 Activity in MCF-7 Breast Cancer Cells and Induces Accumulation of p130-E2F4 Complexes Characteristic of Quiescence* (2000) (147)
- Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development (2010) (145)
- Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers (2011) (144)
- Expression of c‐erbB receptors, heregulin and oestrogen receptor in human breast cell lines (2000) (143)
- EphB4 expression and biological significance in prostate cancer. (2005) (142)
- Activation of Peroxisome Proliferator-activated Receptor γ by a Novel Synthetic Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid Induces Growth Arrest and Apoptosis in Breast Cancer Cells (2003) (139)
- Cytoplasmic Localization of β-Catenin is a Marker of Poor Outcome in Breast Cancer Patients (2010) (138)
- Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens. (1997) (137)
- Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells. (1983) (136)
- Mechanisms of Cyclin-Dependent Kinase Inactivation by Progestins (1998) (135)
- Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin. (1999) (134)
- Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. (2013) (134)
- Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. (1997) (134)
- The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. (2005) (131)
- INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis. (2000) (129)
- Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos. (1995) (129)
- Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells. (2002) (128)
- Estrogen and Progestin Regulation of Cell Cycle Progression (2004) (125)
- Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. (2009) (125)
- Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. (1986) (124)
- Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells (2012) (124)
- Cloning and Characterization of GRB14, a Novel Member of the GRB7 Gene Family (*) (1996) (121)
- Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare. (1984) (120)
- Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models (2001) (119)
- Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells (2014) (116)
- Identification of a human HECT family protein with homology to the Drosophila tumor suppressor gene hyperplastic discs (1998) (114)
- Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle. (1989) (113)
- Deregulated Cyclin D1 Expression Is Associated with Decreased Efficacy of the Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cell Lines (2004) (112)
- Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression (2004) (110)
- Haematopoietic stem cell induction by somite-derived endothelial cells controlled by meox1 (2014) (109)
- A distinct molecular profile associated with mucinous epithelial ovarian cancer (2006) (108)
- Serum gamma-glutamyltransferase activity and protein concentration at birth and after suckling in calves with adequate and inadequate passive transfer of immunoglobulin G. (1993) (107)
- Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma (2003) (107)
- Transcription factor ATF3 links host adaptive response to breast cancer metastasis. (2013) (107)
- EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer (1997) (106)
- Expression of Vascular Endothelial Growth Factor Receptor-3 by Lymphatic Endothelial Cells Is Associated with Lymph Node Metastasis in Prostate Cancer (2004) (105)
- Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling. (2009) (105)
- Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro. (1983) (104)
- Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogens. (1983) (104)
- Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer. (2012) (103)
- Expression of the PEA3 group of ETS‐related transcription factors in human breast‐cancer cells (1997) (103)
- Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells. (1988) (102)
- Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer⋆ (2003) (102)
- Regulation of the Functional Interaction between Cyclin D1 and the Estrogen Receptor (2000) (101)
- Overexpression of the Grb2 gene in human breast cancer cell lines. (1994) (100)
- Expression and function of members of the cytokine receptor superfamily on breast cancer cells (1997) (100)
- The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer (2002) (99)
- Insulin/Insulin-like Growth Factor-I and Estrogen Cooperate to Stimulate Cyclin E-Cdk2 Activation and Cell Cycle Progression in MCF-7 Breast Cancer Cells through Differential Regulation of Cyclin E and p21WAF1/Cip1 * (2001) (99)
- Progestin Inhibition of Progesterone Receptor Gene Expression in Human these steroids is determined in part by the cellular Breast Cancer Cells (1989) (98)
- Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer (2008) (98)
- Preferential Stimulation of Human Progesterone Receptor B Expression by Estrogen in T-47D Human Breast Cancer Cells (*) (1995) (97)
- EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer (2003) (97)
- Lymphatic vessel density and lymph node metastasis in prostate cancer (2005) (97)
- EDD, the Human Hyperplastic Discs Protein, Has a Role in Progesterone Receptor Coactivation and Potential Involvement in DNA Damage Response* (2002) (97)
- MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression. (1994) (97)
- Mechanisms of oestrogen antagonism by nonsteroidal antioestrogens (1982) (96)
- Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1 (2006) (95)
- Meta-Analysis and Gene Set Enrichment Relative to ER Status Reveal Elevated Activity of MYC and E2F in the “Basal” Breast Cancer Subgroup (2009) (95)
- Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer. (2005) (94)
- Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer (2013) (94)
- Pancreatic Intraepithelial Neoplasia in Association With Intraductal Papillary Mucinous Neoplasms of the Pancreas: Implications for Disease Progression and Recurrence (2004) (94)
- Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib. (2007) (93)
- Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy. (2000) (89)
- Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. (1996) (89)
- Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells (2004) (88)
- Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. (2012) (88)
- Overexpression of the cell cycle inhibitor p16INK4A in high-grade prostatic intraepithelial neoplasia predicts early relapse in prostate cancer patients. (2001) (88)
- Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens. (2002) (88)
- Regulation of the ubiquitin‐conjugating enzyme hHR6A by CDK‐mediated phosphorylation (2002) (88)
- Estradiol induction of retinoic acid receptors in human breast cancer cells. (1993) (87)
- Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells (1998) (87)
- Pathways of chemotherapy resistance in castration-resistant prostate cancer. (2011) (87)
- EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival (1998) (86)
- Membranous Expression of Secreted Frizzled-Related Protein 4 Predicts for Good Prognosis in Localized Prostate Cancer and Inhibits PC3 Cellular Proliferation in Vitro (2004) (86)
- Structural Determinants of the Interaction between the erbB2 Receptor and the Src Homology 2 Domain of Grb7* (1997) (86)
- Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers (2011) (86)
- Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen. (1984) (86)
- Cyclin D1 Splice Variants: Polymorphism, Risk, and Isoform-Specific Regulation in Prostate Cancer (2009) (86)
- Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation (1991) (83)
- A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes (2009) (82)
- Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome (2009) (82)
- ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer (2012) (82)
- Steroid hormone receptor gene expression in human breast cancer cells: Inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels (1990) (81)
- Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer. (2009) (81)
- Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy. (2006) (80)
- Cell cycle proteins in epithelial cell differentiation: Implications for breast cancer (2010) (80)
- Differential binding of antiestrogens by rat uterine and chick oviduct cytosol. (1979) (80)
- TCPTP Regulates SFK and STAT3 Signaling and Is Lost in Triple-Negative Breast Cancers (2012) (80)
- Cancer‐associated mis‐sense and deletion mutations impair p16INK4 CDK inhibitory activity (1996) (79)
- Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy (2003) (79)
- Validation Study of the Accuracy of a Postoperative Nomogram for Recurrence After Radical Prostatectomy for Localized Prostate Cancer (2002) (78)
- Expression of the cyclin‐dependent kinase inhibitors p16INK4, p15INK4B and p21Waf1/cip1 in human breast cancer (1995) (78)
- Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer. (2004) (78)
- Up‐regulation of the protein tyrosine phosphatase SHP‐1 in human breast cancer and correlation with GRB2 expression (2000) (76)
- Oncostatin M induces the differentiation of breast cancer cells (1998) (76)
- High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy (2012) (75)
- Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer. (1996) (75)
- Differential Phosphorylation of T-47D Human Breast Cancer Cell Substrates by D1-, D3-, E-, and A-type Cyclin-CDK Complexes* (1997) (74)
- The Common Variant rs1447295 on Chromosome 8q24 and Prostate Cancer Risk: Results from an Australian Population-Based Case-Control Study (2007) (74)
- Androgen regulation of multidrug resistance‐associated protein 4 (MRP4/ABCC4) in prostate cancer (2008) (74)
- Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. (1996) (73)
- Edd, the Murine Hyperplastic Disc Gene, Is Essential for Yolk Sac Vascularization and Chorioallantoic Fusion (2004) (73)
- c-Myc overexpression and endocrine resistance in breast cancer (2006) (73)
- Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells (1998) (72)
- The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia (2005) (72)
- Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells. (1987) (71)
- Prognostic significance of pathologic features in localized prostate cancer treated with radical prostatectomy: implications for staging systems and predictive models. (2001) (71)
- E-selectin up-regulation allows for targeted drug delivery in prostate cancer. (2003) (70)
- Lower levels of nuclear β‐catenin predict for a poorer prognosis in localized prostate cancer (2005) (70)
- Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells. (1988) (70)
- Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix–loop–helix protein Id1 (2005) (70)
- Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists. (2008) (70)
- Cell cycle machinery: links with genesis and treatment of breast cancer. (2008) (69)
- Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells. (2003) (69)
- Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells. (1996) (68)
- Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21. (1997) (68)
- β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression. (2013) (67)
- Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro. (1987) (67)
- EDD Mediates DNA Damage-induced Activation of CHK2* (2006) (67)
- Outcomes of transperineal template‐guided prostate biopsy in 409 patients (2013) (66)
- The E3 Ubiquitin Ligase EDD Regulates S-Phase and G2/M DNA Damage Checkpoints (2007) (65)
- Estrogen Regulation of Cyclin E2 Requires Cyclin D1 but Not c-Myc (2009) (65)
- Quantitative estimates of cytoplasmic and nuclear oestrogen receptors in chick oviduct. Effect of oestrogen on receptor concentration and subcellular distribution. (1976) (65)
- Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53 (2011) (64)
- Microsomal binding sites for nonsteroidal anti-estrogens in MCF 7 human mammary carcinoma cells. Demonstration of high affinity and narrow specificity for basic ether derivatives of triphenylethylene. (1984) (64)
- The role of the bone microenvironment in skeletal metastasis (2012) (64)
- A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells (2006) (64)
- Progesterone receptor regulation by retinoic acid in the human breast cancer cell line T-47D. (1990) (64)
- High Notch1 protein expression is an early event in breast cancer development and is associated with the HER‐2 molecular subtype (2010) (63)
- The binding of tamoxifen to human mammary carcinoma cytosol. (1980) (63)
- Adjuvant chemotherapy in elderly patients with pancreatic cancer (2013) (63)
- Progestin regulation of estrogen receptor messenger RNA in human breast cancer cells. (1990) (62)
- Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer. (1999) (62)
- Epidermal growth factor partially reverses the inhibitory effects of antiestrogens on T 47D human breast cancer cell growth. (1987) (61)
- Effects of 1,25‐dihydroxyvitamin D3 on cell‐cycle kinetics of T 47D human breast cancer cells (1989) (61)
- Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell lines. (1992) (60)
- Inhibitors of cell cycle kinases: recent advances and future prospects as cancer therapeutics. (2012) (60)
- Cooperation of p27Kip1 and p18INK4c in Progestin-Mediated Cell Cycle Arrest in T-47D Breast Cancer Cells (2000) (60)
- The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro (2008) (59)
- 5α‐Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia (2007) (59)
- Aberrant Neuropeptide Y and Macrophage Inhibitory Cytokine-1 Expression Are Early Events in Prostate Cancer Development and Are Associated with Poor Prognosis (2006) (59)
- Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer. (2013) (59)
- Cyclins and breast cancer (2005) (59)
- Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. (2002) (58)
- Cell cycle control by steroid hormones. (1994) (58)
- Tamoxifen-Induced Epigenetic Silencing of Oestrogen-Regulated Genes in Anti-Hormone Resistant Breast Cancer (2012) (58)
- Cyclin D1 Overexpression Induces Progestin Resistance in T-47D Breast Cancer Cells Despite p27Kip1 Association with Cyclin E-Cdk2* (2001) (57)
- Identification of PRG1, a novel progestin-responsive gene with sequence homology to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. (1997) (56)
- Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma (2014) (55)
- Vitamin D Analogue‐Specific Recruitment of Vitamin D Receptor Coactivators (2002) (55)
- HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer (2009) (54)
- Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells (1997) (54)
- Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines (1989) (53)
- Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast‐cancer cells (1992) (53)
- Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX (2012) (53)
- CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER+ disease (2009) (53)
- Recruitment and Activation of Pancreatic Stellate Cells from the Bone Marrow in Pancreatic Cancer: A Model of Tumor-Host Interaction (2011) (53)
- Additive effects of tamoxifen and the farnesyl transferase inhibitor FTI‐277 on inhibition of MCF‐7 breast cancer cell‐cycle progression (2003) (52)
- The thyroxine-binding properties of rat and rabbit serum proteins. (1976) (52)
- 1,25-Dihydroxyvitamin D3 and the Regulation of Human Cancer Cell Replication 1 (1989) (51)
- Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptor. (1986) (51)
- MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome (2010) (51)
- Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers. (2012) (51)
- Oestrogen receptor gene structure and function in breast cancer (1992) (51)
- Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesions (2008) (50)
- Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers (2010) (50)
- Direct transcriptional regulation of the progesterone receptor by retinoic acid diminishes progestin responsiveness in the breast cancer cell line T-47D. (1991) (50)
- Expression and prognostic significance of cyclin B1 and cyclin A in non‐small cell lung cancer (2009) (48)
- The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome (2018) (48)
- Cyclin gene expression and growth control in normal and neoplastic human breast epithelium (1993) (46)
- The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression (2011) (46)
- Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells. (1997) (45)
- Global characterization of signalling networks associated with tamoxifen resistance in breast cancer (2013) (44)
- Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. (1984) (44)
- Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment. (2005) (44)
- Genetic Variants in the Vitamin D Receptor Gene and Prostate Cancer Risk (2005) (43)
- Progestin inhibition of progesterone receptor gene expression in human breast cancer cells. (1989) (43)
- Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines (1996) (43)
- BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast (2008) (43)
- Modulation of estrogen receptor and epidermal growth factor receptor mRNAs by phorbol ester in MCF 7 breast cancer cells. (1989) (43)
- A high-affinity binding site for the antioestrogens, tamoxifen and CI 628, in immature rat uterine cytosol which is distinct from the oestrogen receptor. (1981) (42)
- Inducible expression of cyclin D1 in T‐47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation (1996) (42)
- Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1 (2013) (41)
- Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival (2009) (41)
- Role and prognostic significance of tumor necrosis factor‐related apoptosis‐inducing ligand death receptor DR5 in nonsmall‐cell lung cancer and precursor lesions (2008) (41)
- p27Kip1 Induces Quiescence and Growth Factor Insensitivity in Tamoxifen-treated Breast Cancer Cells (2003) (40)
- A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness. (1984) (40)
- Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site. (1983) (40)
- Regulation of breast cancer cell cycle progression by growth factors, steroids and steroid antagonists (1992) (40)
- Secreted frizzled‐related protein 4 inhibits proliferation and metastatic potential in prostate cancer (2007) (39)
- Mechanisms of prolactin receptor regulation in mammary gland (1993) (39)
- Differential expression of oestrogen regulated genes in breast cancer. (1995) (38)
- Granulosa cell tumors express erbB4 and are sensitive to the cytotoxic action of heregulin-beta2/PE40. (1998) (38)
- Estrogen antagonists in chick oviduct: antagonist activity of eight synthetic triphenylethylene derivatives and their interactions with cytoplasmic and nuclear estrogen receptors. (1981) (38)
- Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor. (2007) (38)
- Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue. (2003) (37)
- Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites. (1987) (37)
- ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer (2014) (37)
- Steroids, growth factors, and cell cycle controls in breast cancer. (1991) (37)
- Low AZGP1 expression predicts for recurrence in margin‐positive, localized prostate cancer (2011) (37)
- Acute effects of growth factors on T-47D breast cancer cell cycle progression. (1993) (36)
- Macropodid marsupial luteinizing hormone: validation of assay procedures and changes in concentrations in plasma during the oestrous cycle in the female tammar wallaby (Macropus eugenii). (1980) (36)
- Effect of gonadectomy, season and the presence of female tammar wallabies (Macropus eugenii) on concentrations of testosterone, luteinizing hormone and follicle-stimulating hormone in the plasma of male tammar wallabies. (1980) (36)
- Direct Crosstalk Between Cancer and Osteoblast Lineage Cells Fuels Metastatic Growth in Bone via Auto‐Amplification of IL‐6 and RANKL Signaling Pathways (2014) (35)
- Control of gonadotrophin secretion in the female tammar wallaby (macropus eugenii). (1980) (35)
- Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin. (1989) (35)
- The pure antiestrogen ICI 182,780 binds to a high‐affinity site distinct from the estrogen receptor (1995) (34)
- Macrophage Inhibitory Cytokine-1 H6D Polymorphism, Prostate Cancer Risk, and Survival (2006) (34)
- Overexpression of the oncogenic signal transducer Gab2 occurs early in breast cancer development (2010) (33)
- Expression and regulation of cyclin genes in breast cancer. (1995) (33)
- Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation (2008) (32)
- Modulation of lactogenic receptors by progestins in cultured human breast cancer cells. (1986) (32)
- Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism (2007) (32)
- Differential effects of tamoxifen and analogs with nonbasic side chains on cell proliferation in vitro. (1985) (32)
- Is year of radical prostatectomy a predictor of outcome in prostate cancer? (2004) (32)
- Growth hormone binding to cultured human breast cancer cells. (1984) (31)
- The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome (2008) (31)
- p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells. (2003) (31)
- High affinity specific antiestrogen binding sites are concentrated in rough microsomal membranes of rat liver. (1984) (31)
- The helix-loop-helix protein Id1 requires cyclin D1 to promote the proliferation of mammary epithelial cell acini. (2008) (30)
- Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells. (2000) (30)
- p14ARF Protein Expression Is a Predictor of Both Relapse and Survival in Squamous Cell Carcinoma of the Anterior Tongue (2005) (30)
- Regulation of growth hormone and epidermal growth factor receptors by progestins in breast cancer cells. (1985) (30)
- Immunohistochemical Level of Unsulfated Chondroitin Disaccharides in the Cancer Stroma Is an Independent Predictor of Prostate Cancer Relapse (2008) (30)
- The thyroxine-binding properties of serum proteins. A competitive binding technique employing sephadex G-25. (1975) (29)
- A Low Abundance Pool of Nascent p21WAF1/Cip1 Is Targeted by Estrogen to Activate Cyclin E·Cdk2* (2001) (29)
- Cyclin E Expression and Outcome in Pancreatic Ductal Adenocarcinoma (2006) (29)
- Glucocorticoid receptor-interacting protein-1 and receptor-associated coactivator-3 differentially interact with the vitamin D receptor (VDR) and regulate VDR-retinoid X receptor transcriptional cross-talk. (2001) (29)
- Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells. (1995) (29)
- PI3K Pathway Activation in Breast Cancer Is Associated with the Basal-Like Phenotype and Cancer-Specific Mortality. (2009) (28)
- Androgen regulation of prolactin‐receptor gene expression in MCF‐7 and MDA‐MB‐453 human breast cancer cells (1992) (28)
- Variants in the Prostate-Specific Antigen (PSA) Gene and Prostate Cancer Risk, Survival, and Circulating PSA (2006) (28)
- Cell cycle effects of iron depletion on T-47D human breast cancer cells. (1985) (28)
- Effects of the progestin antagonist RU 486 on T-47D breast cancer cell cycle kinetics and cell cycle regulatory genes. (1993) (27)
- Inverse relationship between estrogen receptor and epidermal growth factor receptor mRNA levels in human breast cancer cell lines. (1990) (27)
- Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer (2011) (27)
- Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells (2013) (27)
- The Hedgehog signalling pathway as a therapeutic target in early breast cancer development (2009) (26)
- Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4 (2011) (26)
- Non-steroidal antioestrogens : molecular pharmacology and antitumour activity (1981) (24)
- BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation (2010) (24)
- Inhibition of DNA binding and transcriptional activity of a nuclear receptor transcription factor by aurothiomalate and other metal ions. (1991) (24)
- The cyclin-dependent kinase inhibitor p27 (Kip1) regulates both DNA synthesis and apoptosis in mammary epithelium but is not required for its functional development during pregnancy. (2003) (24)
- Microsomal binding sites for antioestrogens in rat liver. Properties and detergent solubilization. (1986) (23)
- Deregulated Cyclin D 1 Expression Is Associated with Decreased Efficacy of the Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cell Lines (2004) (23)
- Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer. (2006) (22)
- Cyclin D 1 , p 53 , and p 21 Waf 1 / Cip 1 Expression Is Predictive of Poor Clinical Outcome in Serous Epithelial Ovarian Cancer (2004) (22)
- Overexpression of p 21 WAF 1 / CIP 1 is an Early Event in the Development of Pancreatic Intraepithelial Neoplasia 1 (2001) (22)
- Inverse regulation of oestrogen receptor and epidermal growth factor receptor gene expression in MCF-7 breast cancer cells treated with phorbol ester (1996) (22)
- Contrasting effects of prenyltransferase inhibitors on estrogen-dependent cell cycle progression and estrogen receptor-mediated transcriptional activity in MCF-7 cells. (2003) (21)
- Hyperthermic potentiation of cytotoxicity of Ro-07-0582 in multicell spheroids. (1977) (21)
- TLE3 Expression Is Associated with Sensitivity to Taxane Treatment in Ovarian Carcinoma (2011) (21)
- Modifications in the aminoether side chain of clomiphene influence affinity for a specific antiestrogen binding site in MCF 7 cells cytosol. (1981) (21)
- The effect of progestins on prolactin receptor gene transcription in human breast cancer cells. (1992) (21)
- The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levels (2007) (20)
- Synergistic and antagonistic effects of progesterone and oestrogen on oestrogen receptor concentration and DNA polymerase activity in chick oviduct (1977) (19)
- Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status (2010) (19)
- Steroid receptors and effects of oestradiol and progesterone on chick oviduct proteins. (1980) (19)
- Transcriptional regulation of prolactin receptor gene expression by sodium butyrate in MCF-7 human breast cancer cells. (1992) (18)
- Cyclin E and prognosis in patients with breast cancer. (2002) (18)
- RON is not a prognostic marker for resectable pancreatic cancer (2012) (18)
- Overexpression of Cyclin D 1 Messenger RNA Predicts for Poor Prognosis in Estrogen Receptor-positive Breast Cancer 1 (1999) (18)
- Low meprin α expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries (2006) (18)
- Amplification, expression, and steroid regulation of the preprogalanin gene in human breast cancer. (1998) (17)
- Live or let die: oestrogen regulation of survival signalling in endocrine response (2007) (17)
- Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines. (1990) (17)
- Retinoid Signaling in Pancreatic Cancer, Injury and Regeneration (2011) (16)
- Gene based prediction of clinically localized prostate cancer progression after radical prostatectomy. (2010) (16)
- Substituted-vinyl hydroxytriarylethylenes, 1-[4-[2-(diethylamino) ethoxy]phenyl]-1-(4-hydroxyphenyl)-2-phenylethylenes: synthesis and effects on MCF 7 breast cancer cell proliferation. (1986) (16)
- INK 4 a Gene Expression and Methylation in Primary Breast Cancer : Overexpression of p 16 INK 4 a Messenger RNA Is a Marker of Poor Prognosis 1 (2000) (16)
- D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding. (1996) (15)
- Chicken oviduct nuclear oestrogen receptors: aspects of steroid hormone action. (1979) (15)
- Synthesis and in vitro evaluation of analogues of avocado-produced toxin (+)-(R)-persin in human breast cancer cells. (2011) (15)
- Stage migration in localized prostate cancer has no effect on the post‐radical prostatectomy Kattan nomogram (2010) (14)
- Identification of downstream targets of estrogen and c-myc in breast cancer cells. (2008) (14)
- HIGH MOLECULAR WEIGHT SOMATOMEDIN-C/IGF-I FROM T47D HUMAN MAMMARY CARCINOMA CELLS: IMMUNOREACTIVITY AND BIOACTIVITY (1983) (14)
- Comparative Biomarker Expression and RNA Integrity in Biospecimens Derived from Radical Retropubic and Robot-Assisted Laparoscopic Prostatectomies (2010) (14)
- The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo. (2015) (14)
- Enhanced RAD21 Cohesin Expression Confers Poor Prognosis and Resistance to Chemotherapy in High Grade Luminal, Basal, and HER 2 Breast Cancers (2014) (13)
- Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes (2011) (13)
- 42. PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality (2011) (13)
- Cyclins and breast cancer. (1996) (13)
- Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells (2013) (13)
- Different points of action of retinoids and anti‐estrogens in G1 phase identified in synchronized T‐47D breast cancer cells (1997) (12)
- Steroidal regulation of cell cycle progression. (2007) (12)
- N-desmethyltamoxifen inhibits growth of MCF 7 human mammary carcinoma cells in vitro. (1983) (11)
- Cytotoxicity of radiosensitizers in multicell spheroids: combination treatment with hyperthermia. (1978) (11)
- Cell cycle control by steroid hormones in breast cancer: implications for endocrine resistance (1995) (10)
- Elevated levels of tumour apolipoprotein D independently predict poor outcome in breast cancer patients (2020) (10)
- Solubilization and characterization of a lactogenic receptor from human placental chorion membranes (1990) (10)
- Coordinate regulation of oestrogen and prolactin receptor expression by sodium butyrate in human breast cancer cells. (1992) (10)
- LMO4 expression in squamous cell carcinoma of the anterior tongue (2011) (10)
- Regulation of prolactin receptor expression by the tumour promoting phorbol ester 12‐O‐tetradecanoylphorbol‐13‐acetate in human breast cancer cells (1993) (9)
- Prognostic Significance of p 53 Nuclear Accumulation in Localized Prostate Cancer Treated with Radical Prostatectomy 1 (2000) (9)
- Effect of ionic strength and ionic composition of assay buffers on the interaction of thyroxine with plasma proteins. (1975) (9)
- Macropodid marsupial testicular gonadotrophin receptors and their use in assays for marsupial gonadotrophins. (1981) (9)
- High activity, soluble, bacterially expressed human vitamin D receptor and its ligand binding domain (1996) (8)
- Macrophage inhibitory cytokine-1 (MIC-1) in epithelial neoplasia (2001) (8)
- Messina: A Novel Analysis Tool to Identify Biologically Relevant Molecules in Disease (2009) (8)
- BINDING PROPERTIES AND LIGAND SPECIFICITY OF AN INTRACELLULAR BINDING SITE WITH SPECIFICITY FOR SYNTHETIC OESTROGEN ANTAGONISTS OF THE TRIPHENYLETHYLENE SERIES (1982) (7)
- A molecular prognostic nomogram for resectable pancreatic cancer. (2011) (7)
- RB in breast cancer (2010) (7)
- EXPRESSION OF S100A2 CALCIUM-BINDING PROTEIN PREDICTS RESPONSE TO PANCREATECTOMY FOR PANCREATIC CANCER (2008) (7)
- Hormonal Control of Breast Cancer Cell Cycle Progression (1994) (6)
- The transcapillary exchange of thyroid hormones and thyroxine‐binding proteins between blood and tissue fluids. (1976) (6)
- International Congress on Hormonal Steroids and Hormones and Cancer Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells (2003) (6)
- Cyclin-dependent kinases as downstream targets of oestrogen action: potential prognostic indicators and therapeutic targets (1997) (6)
- Chapter 12 Oestrogen actions (1988) (6)
- Aberrent hedgehog signaling is an early event in breast cancer development. (2009) (6)
- Assignment of the human GRB14 gene to chromosome 2q22-q24 by fluorescence in situ hybridization. (1996) (5)
- Estrogen Regulation of Cell Cycle Progression (2001) (5)
- A Low Abundance Pool of Nascent p21 Is Targeted by Estrogen to Activate Cyclin E Cdk2* (2001) (5)
- Comparative effects of gold on the interactions of transcription factors with DNA. (1993) (5)
- 291 Growth hormone receptors in human breast cancer: Correlation with oestrogen receptor status (1983) (4)
- Total plasma thyroxine concentrations in horses, pigs, cattle, and sheep: anion exchange resin chromatography and ceric-arsenite colorimetry. (1973) (4)
- Thyroxine-binding proteins in sheep serum. (1974) (4)
- Human growth hormone binds to lactogenic receptors in bovine, ovine and rat adrenals. (1988) (4)
- The interaction of estrogen- and antiestrogen-receptor complexes with polynucleotides. (1983) (4)
- The third human isoform of 6-phosphofructo-2-kinasefructose-2,6-bisphosphatase (PFKFB3) Map position 10p14–p15 (1997) (4)
- Differential expression of estrogen-regulated genes in breast-cancer (1995) (4)
- 29. c-MYC gene amplification is associated with a poor prognosis in invasive ductal carcinoma (2010) (3)
- Endocrine-Related Cancer ( 2011 ) 18 R 103 – R 123 Pathways of chemotherapy resistance in castration-resistant prostate cancer (2011) (3)
- A study of methylated glutathione s-transferase 1 (mGSTP1)as a potential plasma epigenetic marker of response to chemotherapy and prognosis in men with castration-resistant prostate cancer (CRPC). (2011) (3)
- ANZ1001 SORBET: Study of Oestrogen Receptor Beta and Efficacy of Tamoxifen-A single-arm, phase II study of the efficacy of tamoxifen in triple-negative but estrogen receptor beta-positive metastatic breast cancer. (2011) (2)
- Human Cancer Biology Cyclin D 1 Splice Variants : Polymorphism , Risk , and Isoform-Specific Regulation in Prostate Cancer (2009) (2)
- Progestin Regulation of Cell Proliferation in the Breast and Endometrium (1995) (2)
- Edd, the Murine Ortholog of the hyperplastic discs (hyd) Gene, Is Essential for Yolk Sac Vascularization and Chorioallantoic Fusion (2004) (2)
- Effect of season and pregnancy on total plasma thyroxine concentrations in sheep. (1974) (2)
- Cytokines' profiles to predict chemotherapy outcome in castration-resistant prostate cancer (CRPC). (2011) (2)
- ANZ1001 SORBET: Study of Oestrogen Receptor Beta and Efficacy of Tamoxifen--A single-arm, phase II study of the efficacy of tamoxifen in triple-negative but estrogen receptor beta-positive metastatic breast cancer. (2011) (2)
- A novel method of bladder neck imbrication to improve early urinary continence following robotic-assisted radical prostatectomy (2013) (2)
- Cancer Cell Viability in Pancreatic Cancer Sirtuin-1 Regulates Acinar-to-Ductal Metaplasia and Supports (2013) (1)
- Endocrine-Related Cancer ( 2003 ) 10 179 – 186 International Congress on Hormonal Steroids and Hormones and Cancer Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells (2003) (1)
- Steroidal control of cell proliferation in the breast and breast cancer (2020) (1)
- Effect of thyroidectomy on the concentration of plasma thyroxine-binding proteins in sheep. (1974) (1)
- Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX (2012) (1)
- Use of the novel biomarker (HOXB2) to predict response to pancreatectomy for pancreatic cancer (2007) (1)
- Estrogens, Cell Proliferation and Breast Cancer (2008) (1)
- Transcriptional Regulation by Gold(I) Thiolates Involving Interaction With Conserved Cysteine Residues in the Photo-Oncogene Products Jun and Fos (1994) (1)
- RON is not a prognostic marker for resectable pancreatic cancer (2012) (1)
- Chapter 4 Progestin regulation of cellular proliferation (1996) (1)
- Abstract S6-8: Hedgehog Ligand Overexpression Predicts Poor Outcome in Breast Cancer and Is a Potential Therapeutic Target for Metastatic Disease (2010) (1)
- 755 poster ENHANCED RAD21 COHESIN EXPRESSION CONFERS POOR PROGNOSIS AND RESISTANCE TO CHEMOTHERAPY IN HIGH GRADE LUMINAL, BASAL AND HER2 BREAST CANCERS (2011) (1)
- 314 The Novel Biomarker (HOXB2) Predicts Response to Pancreatectomy for Pancreatic Cancer (2008) (1)
- Antiestrogens and the Cell Cycle (2009) (1)
- Wnt-Signaling genes and their potential as tumor markers for epithelial ovarian cancer (2006) (0)
- 2 Antiestrogens and the Cell Cycle (2019) (0)
- Mechanisms of Anti-Estrogen and Retinoid Inhibition of Breast Cancer Cell Proliferation (1996) (0)
- Studies on plasma thyroxine-binding proteins (1974) (0)
- Immunohistochemistry of methyl guanine DNA methyltransferase (MGMT) in () normal bronchial epitheliu (2011) (0)
- Expression of the androgen receptor and its association with disease outcome in breast cancer (2006) (0)
- Cyclin D1 and Cyclin E as Markers of Therapeutic Responsiveness in Breast Cancer (2001) (0)
- bal Levels of Specific Histone Modifications and an enetic Gene Signature Predict Prostate Cancer B & P gression and Development (2010) (0)
- 332 Antitumour activity in vitro of nonsteroidal antioestrogens with reduced affinity for a high affinity antioestrogen binding site (AEBS) (1983) (0)
- Estradici Induction of Retinoic Acid Receptors in Human Breast Cancer Cells 1 (2006) (0)
- 35. Hedgehog overexpression is regulated by stromal interactions and predicts for poor outcome in invasive ductal carcinoma (2012) (0)
- 34. Prediction of outcome of early luminal breast cancer is improved using a biomarker panel which includes KI-67 and P53 (2012) (0)
- ErbB 2-mediated mammary tumor progression (2013) (0)
- Overexpression of the human hyperplastic discs protein EDD is an independent predictor of relapse in serous epithelial ovarian cancer. (2004) (0)
- Abstracts presented at the 37th Annual Scientific Meeting, 16‐19 May 2004, Sydney, New South Wales (2004) (0)
- 8. Cyc1ins and breast cancer (1996) (0)
- 1122 Identifying Putative MiRNAs Mediators of Radiotherapy Resistance in Breast Cancer (2012) (0)
- Inactivation by Progestins Mechanisms of Cyclin-Dependent Kinase (1997) (0)
- 41. Differences in cell cycle and apoptotic biomarker expression between molecular subtypes of invasive ductal breast carcinoma (2011) (0)
- Stage migration and the Kattan nomogram (2008) (0)
- Expression and Regulation of Retinoic Acid Receptors in Human Breast Cancer Cells 1 (2006) (0)
- 300 CAN THE GLEASON GRADE AT THE SITE OF A POSITIVE MARGIN PREDICT BIOCHEMICAL FAILURE POST RADICAL PROSTATECTOMY (2010) (0)
- CAN-10-0911 Cancer esearch or and Stem Cell Biology sine Phosphorylation Profiling Reveals the Signaling R work Characteristics of Basal Breast Cancer Cells (2010) (0)
- Interleukin 6 promotes the growth of breast cancer bone metastasis (2011) (0)
- Expression and Regulation of Retinoic Acid Receptors in Human Breast Cancer Cells1 (2006) (0)
- Nuclear beta-catenin as a marker of outcome in localized prostate cancer. (2004) (0)
- Abstract 2843: Tumor macrophages utilize ATF3 to promote breast cancer metastasis (2011) (0)
- Third International Conference on Spheroids in Cancer Research (July 27-28, 1987). Cambridge, UK. Abstracts. (1987) (0)
- 111In-NLS-7G3, A novel auger electron-emitting radiotherapeutic targeting the leukemic stem cell epitope CD123 (2009) (0)
- Gene-based prediction of PSA recurrence for clinically localized prostate cancer patients. (2009) (0)
- TRANSDIFFERENTIATION OF BONE MARROW DERIVED STEM CELLS INTO MATURE PANCREATIC ACINAR CELLS (2008) (0)
- Estrogen/Estrogen Antagonist Regulation of the Cell Cycle in Breast Cancer Cells (2002) (0)
- Cells by Epidermal Growth Factor and Insulin the Antiestrogen Hydroxyclomiphene on Human Breast Cancer Modulation of the Growth-inhibitory Effects of Progestins and Updated Version (2006) (0)
- Cancer esearch or and Stem Cell Biology sine Phosphorylation Profiling Reveals the Signaling R work Characteristics of Basal Breast Cancer Cells (2010) (0)
- OVEREXPRESSION OF THE HUMAN HYPERPLASTIC DISCS PROTEIN EDD IS AN INDEPENDENT PREDICTOR OF RELAPSE IN SEROUS OVARIAN CANCER (2004) (0)
- Changes in insulin receptor levels during the cell cycle in l1210 leukemia. Abstr. (1979) (0)
- Substituted-Vinyl Hydroxytriarylethylenes, 1-(4-(2-(Diethylamino)ethoxy)phenyl)-1-(4-hydroxyphenyl)-2-phenylethylenes: Synthesis and Effects on MCF 7 Breast Cancer Cell Proliferation. (1987) (0)
- 0-96. Cyclin D1 overexpression predicts for poor prognosis in ER positive breast cancer (1997) (0)
- 1079: Neuropeptide Y Expression is increased in the Progression from Benign to Malignant Prostate Epithelium and Predicts Outcome after Radical Prostatectomy (2004) (0)
- 185 Oestrogen receptor content and sensitivity of human cell lines to tamoxifen (1983) (0)
- MP-05.16: Should Experienced Open Prostatic Surgeons Convert to Robotic Surgery? The Real Learning Curve for a Single Surgeon (2009) (0)
- Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells (2014) (0)
- PP 68 Cytokines' profiles to predict chemotherapy outcome in castration resistant prostate cancer (CRPC) (2011) (0)
- [Control mechanisms of ovalbumin and conalbumin synthesis in chicken oviducts by estradiol and progesterone. Studies on estradiol receptor and the effects of an anti-estrogen, tamoxifen]. (1980) (0)
- Estrogen Receptor Assays in Breast Cancer. Laboratory Discrepancies and Quality Assurance (1982) (0)
- Progestins BothStimulate andInhibit Breast Cancer CellCycle Progression while Increasing Expression ofTransforming GrowthFactor ox,Epidermal GrowthFactor Receptor, c-fos, andc-myc Genes (1991) (0)
- ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer (2014) (0)
- 3517 POSTER The novel biomarker (HOXB2) predicts response to pancreatectomy for pancreatic cancer (2007) (0)
- Molecular pathologic phenotypes and outcome in adenocarcinoma of the ampulla of Vater. (2011) (0)
- 97. Steroid regulation of breast cancer cell proliferation (2003) (0)
- 30. MAL2 and tumour protein D52 (TPD52) overexpression in ovarian carcinoma, association with histological subtype and clinical outcome (2011) (0)
- 1471 QUALITY OF LIFE OUTCOMES AMONGST MEN UNDERGOING CONTEMPORARY TECHNIQUES FOR THE TREATMENT OF LOCALISED PROSTATE CANCER: A PROSPECTIVE STUDY (2012) (0)
- 320 Mechanisms of action of antioestrogens as antitumour agents in vitro (1983) (0)
- Human Breast Cancer Cells Expression and Regulation of Retinoic Acid Receptors in (1992) (0)
- A heterologous radioimmunoassay for tammar wallaby luteinizing hormone (1977) (0)
- 1130: PTEN Expression in Premalignant Prostate Disease (2007) (0)
- 151 QUALITY OF LIFE CHANGES FOLLOWING RADICAL PROSTATECTOMY: A PROSPECTIVE COMPARISON OF ROBOTIC & OPEN TECHNIQUES (2011) (0)
- Elevated multidrug resistance-associated protein 4 (MRP4) expression in localized prostate cancer-A potential androgen regulated protein. (2006) (0)
- Intrinsic subtype and its clinical significance in early node-negative breast cancer: Results from two randomized trials of adjuvant chemoendocrine therapy. (2012) (0)
- Radioimmunoassay and radioreceptor assay for wallaby follicle stimulating hormone (1977) (0)
- The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro (2008) (0)
- Advances in Brief p 27 Kip 1 Induces Quiescence and Growth Factor Insensitivity in Tamoxifen-treated Breast Cancer Cells 1 (2003) (0)
- 40. Cytoplasmic localisation of β catenin is a marker of poor outcome in breast cancer patients (2011) (0)
- Molecular markers that predict for recurrence in men with margin-positive localized prostate cancer. (2010) (0)
- Abstract A4: Whole genome sequencing of free circulating DNA from plasma of HGSOC patients (2013) (0)
- 673 Open versus robotic-assisted radical prostatectomy: A comparison of urinary and sexual quality of life outcomes (2012) (0)
- Identification of candidate biomarkers of therapeutic response to docetaxel in hormone-refractory prostate cancer by proteomic profiling. (2009) (0)
- Steroid and steroid antagonist regulation of cyclin D1 and c-myc gene expression in T-47D breast cancer cells (1993) (0)
- A note on the estimation of thyroxine-binding parameters. (1974) (0)
- ARFProtein Expression Is a Predictorof BothRelapse andSurvival in Squamous Cell Carcinoma of theAnterior Tongue (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robert Lyndsay Sutherland?
Robert Lyndsay Sutherland is affiliated with the following schools:
